Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 13 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 11447830

    Gene signatures to predict drug response in cancer

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  2. US 11446302

    Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

    The Board of Regents of the University of Texas System · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  3. US 11439650

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  4. US 11434233

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  5. US 11426464

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  6. US 11426448

    Methods for treatment of erectile dysfunction with sonic hedgehog compounds

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  7. US 11426420

    Inhibitors of short-chain dehydrogenase activity for treating coronary disorders

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  8. US 11427816

    Cancer treatment through RLIP76 partial depletion

    The Board of Regents of the University of Texas System · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  9. US 11421010

    T cells expressing membrane-anchored IL-12 for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted
  10. US 11413240

    Methylene blue solution for the treatment of oral lesions

    The Board of Regents of the University of Texas System · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  11. US 11413336

    Coccidioides antigens and methods of their use

    The Board of Regents of the University of Texas System · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  12. US 11413329

    Cancer cell trap

    The Board of Regents of the University of Texas System · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  13. US 11407752

    Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione analogues

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  14. US 11406643

    Targeting kinases for the treatment of cancer metastasis

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  15. US 11406722

    Nanodroplets with improved properties

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  16. US 11400096

    Small molecules for the treatment of autoimmune disorders

    The Board of Regents of the University of Texas System · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  17. US 11401510

    Generation of airway basal stem cells from human pluripotent stem cells

    The Board of Regents of the University of Texas System · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  18. US 11400108

    Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

    The Board of Regents of the University of Texas System · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  19. US 11397188

    Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  20. US 11395838

    Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome

    The Board of Regents of the University of Texas System · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  21. US 11396647

    Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

    The Board of Regents of the University of Texas System · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  22. US 11389433

    BRD4 inhibitor treatment of IgE-mediated diseases

    The Board of Regents of the University of Texas System · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  23. US 11389459

    Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

    The Board of Regents of the University of Texas System · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  24. US 11382899

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted